Approval · Notice of Compliance 11792 · 2010
HY-50: Notice of Compliance 11792
Issued October 7, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11792
- Date
- October 7, 2010
- Company
- Central Sales LimitedBrampton, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in ownership
- Therapeutic class
- Antiarthritic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HY-50 | 02238566 | Marketed |
Medicinal ingredients
- HYALURONATE SODIUM 17 MG per ML